Symbol="KROS"
AssetType="Common Stock"
Name="Keros TherapeuticsÂ Inc"
Description="Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts."
CIK="1664710"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1153192000"
EBITDA="-128805000"
PERatio="None"
PEGRatio="None"
BookValue="12.01"
DividendPerShare="0"
DividendYield="0"
EPS="-4.29"
RevenuePerShareTTM="0.824"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.402"
RevenueTTM="20000000"
GrossProfitTTM="-87265000"
DilutedEPSTTM="-4.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="95"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="68.42"
PriceToBookRatio="5.74"
EVToRevenue="57.24"
EVToEBITDA="-14.45"
Beta="1.084"
num_52WeekHigh="59.96"
num_52WeekLow="26.34"
num_50DayMovingAverage="44.39"
num_200DayMovingAverage="46.35"
SharesOutstanding="29584200"
DividendDate="None"
ExDividendDate="None"
symbol="KROS"
open="39.05"
high="39.36"
low="38.41"
price="38.96"
volume="125980.00"
latest_trading_day="2023-07-07"
previous_close="38.98"
change="-0.02"
change_percent="-0.0513%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="73"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="27"
Volume_recent_avg="229199"
Change_recent_avg="-0.1"
Delta_recent_avg="2.37"
Variance_recent_avg="1.18"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="27"
Aroon_momentum_negative="73"
image_negative_thumbnail_id_1="498"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0107.jpeg"
image_negative_thumbnail_id_2="149"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0027.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="1001"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_positive_thumbnail_id_2="612"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0096.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
